Piper Sandler Lifts Viatris Price Target to $12 Citing Brand Strength and New Product Momentum
Piper Sandler raised its price target on Viatris (NASDAQ: VTRS) to $12.00 from $9.00 while retaining a Neutral rating, pointing to robust branded business performance across geographies and steady contributions from recent launches in developed markets. The firm notes shares have rallied roughly 33% since the start of the fourth quarter of 2025 ami…